» Articles » PMID: 36467294

Genomic Investigation to Identify Sources of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Personnel in an Acute Care Hospital

Overview
Date 2022 Dec 5
PMID 36467294
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying the source of healthcare personnel (HCP) coronavirus disease 2019 (COVID-19) is important to guide occupational safety efforts. We used a combined whole genome sequencing (WGS) and epidemiologic approach to investigate the source of HCP COVID-19 at a tertiary-care center early in the COVID-19 pandemic.

Methods: Remnant nasopharyngeal swab samples from HCP and patients with polymerase chain reaction-proven COVID-19 from a period with complete sample retention (14 March 2020 to 10 April 2020) at Rush University Medical Center in Chicago, Illinois, underwent viral RNA extraction and WGS. Genomes with >90% coverage underwent cluster detection using a 2 single-nucleotide variant genetic distance cutoff. Genomic clusters were evaluated for epidemiologic linkages, with strong linkages defined by evidence of time/location overlap.

Results: We analyzed 1031 sequences, identifying 49 clusters that included ≥1 HCP (265 patients, 115 HCP). Most HCP infections were not healthcare associated (88/115 [76.5%]). We did not identify any strong epidemiologic linkages for patient-to-HCP transmission. Thirteen HCP cases (11.3%) were attributed to a potential patient source (weak evidence involving nonclinical staff that lacked location data to prove or disprove contact with patients in same cluster). Fourteen HCP cases (12.2%) were attributed to HCP source (11 with strong evidence).

Conclusions: Using genomic and epidemiologic data, we found that most HCP severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were not healthcare associated. We did not find strong evidence of patient-to-HCP transmission of SARS-CoV-2.

Citing Articles

Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a County Jail.

Adediran T, Zawitz C, Piriani A, Bendict E, Thiede S, Barbian H Open Forum Infect Dis. 2024; 11(2):ofad675.

PMID: 38379564 PMC: 10878058. DOI: 10.1093/ofid/ofad675.

References
1.
Rickman H, Rampling T, Shaw K, Martinez-Garcia G, Hail L, Coen P . Nosocomial Transmission of Coronavirus Disease 2019: A Retrospective Study of 66 Hospital-acquired Cases in a London Teaching Hospital. Clin Infect Dis. 2020; 72(4):690-693. PMC: 7337682. DOI: 10.1093/cid/ciaa816. View

2.
Lumley S, Constantinides B, Sanderson N, Rodger G, Street T, Swann J . Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals. J Infect. 2021; 83(4):473-482. PMC: 8316632. DOI: 10.1016/j.jinf.2021.07.034. View

3.
Klompas M, Baker M, Rhee C, Tucker R, Fiumara K, Griesbach D . A SARS-CoV-2 Cluster in an Acute Care Hospital. Ann Intern Med. 2021; 174(6):794-802. PMC: 7924623. DOI: 10.7326/M20-7567. View

4.
Taylor J, Carter R, Lehnertz N, Kazazian L, Sullivan M, Wang X . Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(37):1288-1295. PMC: 7498172. DOI: 10.15585/mmwr.mm6937a3. View

5.
Wee L, Ko K, Conceicao E, Sim J, Rahman N, Tan S . Linking sporadic hospital clusters during a community surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) B.1.617.2 delta variant: The utility of whole-genome sequencing. Infect Control Hosp Epidemiol. 2022; 44(6):1014-1018. PMC: 10262163. DOI: 10.1017/ice.2022.106. View